4 completed, 4 unknown, 3 recruiting, 2 active not recruiting. 7 Not applicable, 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Terminated 2, Unknown 2, Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Lymphoma, Hodgkin: new trials by email Literature Review of Lymphoma, Hodgkin trials Research Report on Lymphoma, Hodgkin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial Interrupted Sedentary Time Intervention - Lymphoma, Lymphoma, Hodgkin | Not applicable | Recruiting | Dana-Farber Cancer Institute | 24 | 2025-06-05 | 2026-04-13 |
| Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases Miltenyi CliniMACS Prodigy ® system - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Recruiting | University of Florida | 20 | 2024-05-03 | 2026-06-04 |
| Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours Ocoxin Oral solution - Advanced Cancer, Advanced Solid Tumor | Not applicable | Unknown | Catalysis SL | 40 | 2024-04-28 | 2024-04-12 |
| STAY-STRONG Study of Exercise Training During Chemotherapy Resistance Exercise Training - Lymphoma, B-Cell, Lymphoma, Hodgkin | Not applicable | Completed | Copenhagen University Hospital, Rigshospitalet | 42 | 2022-10-25 | 2025-12-08 |
| A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant Pharmacokinetics - Lymphoma, Lymphoma, B-Cell | Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 39 | 2022-09-09 | 2026-03-06 |
| Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG Intervention - Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin | Not applicable | Active not recruiting | Assistance Publique - Hôpitaux de Paris | 128 | 2022-04-01 | 2025-08-13 |
| Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma Myo-Inositol and D-Chiro-Inositol (MIC) - Lymphoma, Hodgkin, Menstrual Irregularity | Completed | University of Bari Aldo Moro | 90 | 2020-02-07 | 2022-06-08 | |
| Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma OT-82 Dose Escalation, OT-82 Dose Expansion - Lymphoma, Lymphoma, Non-Hodgkin | Phase 1 | Unknown | Oncotartis, Inc. | 50 | 2019-07-29 | 2020-10-23 |
| Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response MOOVCARE - Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse | Not applicable | Terminated | Weprom | 52 | 2017-07-12 | 2021-04-28 |
| Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation Plerixafor 0.12 mg/kg - Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin | Phase 2 | Unknown | Hospital Universitario Dr. Jose E. Gonzalez | 20 | 2017-05-10 | 2017-08-10 |
| Precision Exercise in Children With Malignant Hemopathies Sport Therapy - Leukemia, Myeloid, Acute, Leukemia, B-cell | Not applicable | Unknown | University of Milano Bicocca | 380 | 2017-04-03 | 2024-01-02 |
| Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III Chemotherapy - Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin | Recruiting | Samsung Medical Center | 600 | 2017-03-01 | 2025-05-21 | |
| Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine Bendamustine, Cyclophosphamide - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Phase 1 | Completed | University of Arizona | 50 | 2016-11-29 | 2025-11-10 |
| MELT - MRI Evaluation of Lymphoma Treatment Lymphoma, Hodgkin | Completed | University College, London | 58 | 2011-09-01 | 2015-12-03 | |
| T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE Ara C, Mesna, Cyclophosphamide - Leukemia, Cancer | Not applicable | Terminated | Baylor College of Medicine | 26 | 2007-10-01 | 2016-04-22 |
Hodgkin Disease (15) · Lymphoma, Non-Hodgkin (10) · Lymphoma (9) · Leukemia (3) · Leukemia, Myeloid, Acute (3) · Lymphoma, B-Cell (3) · Lymphoma, T-Cell (3) · Neoplasms (3) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Lymphoma, Follicular (2) · Motor Activity (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Adrenoleukodystrophy (1) · Burkitt Lymphoma (1)
Hemic and Lymphatic Diseases (15) · Immune System Diseases (15) · Immunoproliferative Disorders (15) · Lymphatic Diseases (15) · Lymphoproliferative Disorders (15) · Neoplasms by Histologic Type (15) · Neoplasms (12) · Lymphoma (6) · Pathological Conditions, Signs and Symptoms (5) · Hematologic Diseases (4) · Pathologic Processes (4) · Behavior (3) · Bone Marrow Diseases (3) · Leukemia, Lymphoid (3) · Leukemia, Myeloid (3)
Cyclophosphamide (2) · Bendamustine Hydrochloride (1) · Cytarabine (1) · Drug Therapy (1) · Inositol (1) · Mesna (1) · Methods (1) · Ocoxin (1) · Pharmacokinetics (1) · Resistance Training (1) · Therapeutics (1) · plerixafor (1)
Assistance Publique - Hôpitaux de Paris (1) · Baylor College of Medicine (1) · Catalysis SL (1) · Copenhagen University Hospital, Rigshospitalet (1) · Dana-Farber Cancer Institute (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · Memorial Sloan Kettering Cancer Center (1) · Oncotartis, Inc. (1) · Samsung Medical Center (1) · University College, London (1) · University of Arizona (1) · University of Bari Aldo Moro (1) · University of Florida (1) · University of Milano Bicocca (1) · Weprom (1)
United States (6) · France (2) · Italy (2) · Denmark (1) · Honduras (1) · Mexico (1) · South Korea (1) · United Kingdom (1)
Andrea Biondi, MD, PhD (1) · Christina Dieli-Conwright, MD, PhD (1) · David Gomez Almaguer, md (1) · Emmanuel Katsanis, MD (1) · Eric Rowinsky, MD (1) · Jordan Milner, MD (1) · Katell LE DU, MD (1) · Parastoo Dahi, MD (1) · Robert Krance, MD (1) · Seok Jin Kim, MD, PhD (1) · Stuart A Taylor, Prof (1)
PMID 19720922, PMID 20067838, PMID 20530974, PMID 28067870, PMID 29908231, PMID 31618456, PMID 32582591, PMID 35460929, PMID 35847727, PMID 39606939, PMID 40270968